Literature DB >> 17590268

Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age.

José M Martínez-Jabaloyas1, Alfonso Queipo-Zaragozá, Raúl Rodríguez-Navarro, José Antonio Queipo-Zaragozá, Manuel Gil-Salom, Pascual Chuan-Nuez.   

Abstract

OBJECTIVES: To determine the relationship between the ADAM questionnaire and the sexual hormonal levels in a male population older than 50 yr, and to know the predictive capacity of this questionnaire with regard to biochemical hypogonadism in the ageing male.
METHODS: A prospective study was carried out on 230 Spanish men. Patients were evaluated by clinical history. The ADAM questionnaire and the Yesavage's Geriatric Depression Scale were completed by each patient. Blood tests were performed including total testosterone, SHBG, free testosterone (FT), dehidroepiandrosterone sulfate (DHEA-S), androstenedione, 17-beta-estradiol, FSH, LH, and prolactin. The relationship between positive ADAM questionnaire and age, clinical and sociodemographic backgrounds, and hormone levels was analysed by means of uni- and multivariate tests. The capacity of the ADAM questionnaire to predict biochemical hypogonadism was determined with a chi-square test.
RESULTS: ADAM questionnaire (excluding men with positive Yesavage's Scale) was positive in 140 patients (67.9%). With respect to clinical backgrounds, diabetes mellitus and age had a significant relationship with an ADAM-positive questionnaire. With respect to hormones, FT and DHEA-S levels were significantly lower when the ADAM questionnaire was positive. In the multivariate analysis, age, FT, and diabetes were independently related to an ADAM-positive questionnaire. Prevalence of biochemical hypogonadism (FT<0.228 nmol/l) was 24.6%. The ADAM test had a sensitivity of 84.0% and a specificity of 36.6% to detect biochemical hypogonadism.
CONCLUSIONS: FT is inversely related to the ADAM-positive questionnaire, independently of age. The ADAM questionnaire is a valid test to detect hypogonadism but has low specificity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590268     DOI: 10.1016/j.eururo.2007.05.021

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

Review 1.  How to recognize late-onset hypogonadism in men with sexual dysfunction.

Authors:  Giovanni Corona; Giulia Rastrelli; Linda Vignozzi; Edoardo Mannucci; Mario Maggi
Journal:  Asian J Androl       Date:  2012-01-30       Impact factor: 3.285

2.  MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto®.

Authors:  Jay Lee; Gerald Brock; Jack Barkin; Nathan Bryson; Matthew A Gronski; Ross Ormsby
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

3.  Hypogonadism: Easy to define, hard to diagnose, and controversial to treat.

Authors:  Joshua Sterling; Aaron M Bernie; Ranjith Ramasamy
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

Review 4.  Predicting low testosterone in aging men: a systematic review.

Authors:  Adam C Millar; Adrian N C Lau; George Tomlinson; Alan Kraguljac; David L Simel; Allan S Detsky; Lorraine L Lipscombe
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

5.  Androgen Deficiency in Aging Males: Translation and Validation Study of the Iranian Version.

Authors:  Mansoureh Ashghali-Farahani; Alice Khachian; Parya Vakilian; Mokhtar Mahmoudi
Journal:  Iran J Nurs Midwifery Res       Date:  2021-03-05

Review 6.  Off label therapies for testosterone replacement.

Authors:  Lorenzo DiGiorgio; Hossein Sadeghi-Nejad
Journal:  Transl Androl Urol       Date:  2016-12

7.  The Epidemiological Characteristics of Late-Onset Hypogonadism in Chinese Middle-Aged and Elderly Men: Two Cross-Sectional Studies in the Same Community.

Authors:  Shan-Jie Zhou; Ming-Jia Zhao; Yi-Hong Yang; Di Guan; Zhi-Guang Li; Yu-Dang Ji; Bao-Long Zhang; Xue-Jun Shang; Cheng-Liang Xiong; Yi-Qun Gu
Journal:  Am J Mens Health       Date:  2020 Nov-Dec

8.  The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism.

Authors:  O Mohamed; R E Freundlich; H K Dakik; E D Grober; B Najari; L I Lipshultz; M Khera
Journal:  Int J Impot Res       Date:  2009-08-06       Impact factor: 2.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.